Monitoring Anti-Rituximab Antibodies in Myasthenia Gravis Affects the Time to Event During Rituximab Treatment.

Charlotte Héraud, Saskia Bresch,Véronique Bourg, Cassandre Landes-Château, Caroline Ruetsch-Chelli,Michel Ticchioni,Barbara Seitz-Polski,Christine Lebrun-Frenay

Journal of Neurology（2025）

Cited 0|Views0

Key words

Myasthenia gravis,Rituximab,Anti-drug antibodies

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined